loader image
Saturday, February 24, 2024
75.7 F
McAllen
We Welcome your Press Release
- Advertisement -

Office Of The Governor Statement On COVID-19 Monoclonal Antibody Treatment

Array

Translate to Spanish or other 102 languages!

overnor Abbott’s doctor prescribed Regeneron's monoclonal antibody therapy treatment, which is available at no cost to all Texans who get a doctor’s referral. Image for illustration purposes
Governor Abbott’s doctor prescribed Regeneron’s monoclonal antibody therapy treatment, which is available at no cost to all Texans who get a doctor’s referral. Image for illustration purposes

Mega Doctor News

- Advertisement -

AUSTIN – Office of the Governor Communications Director Mark Miner today issued the following statement:

“Governor Abbott’s doctor prescribed Regeneron’s monoclonal antibody therapy treatment, which is available at no cost to all Texans who get a doctor’s referral. It is recommended that Texans testing positive for COVID-19 seek this antibody therapeutic drug because of its effectiveness to help keep people out of hospitals. Today, the Governor announced the continued expansion of COVID-19 Antibody Infusion Centers across Texas. That is in addition to more than 140 providers that are providing antibody treatment at hospitals and clinics across the state.”

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Epidemiology Expert Dr. Scott Lillibridge Takes Helm at DHR Health Institute for Research and Development

Dr. Lillibridge's distinguished federal career with the Centers for Disease Control and Prevention (CDC) includes serving as Special Assistant to the Secretary for the Department of Health and Human Services, Director for the CDC Bioterrorism Preparedness and Response Program, and Medical Director for the US Office of Foreign Disaster Assistance (USAID).

Aida Coronado Garcia’s Back to the Beginning, A Day of Leadership at Perkins Middle School     

Coronado Garcia's visit was more than just a ceremonial return; it was an interactive and insightful activity into the daily operations and challenges of running a middle school.

New Cell-Based Immunotherapy Offered for Melanoma

Washington University doctors and researchers were involved in clinical trials that led to the FDA approval.

South Texas College Launches Advanced Nursing Simulation Technology with Multimillion-Dollar Support

The announcement was made even more significant by the support from VIDA
- Advertisement -
×